Muchly appreciated Shabandri. You have mail from me, whenever you get a chance would be great! I am sure you will get hammered so thanks for that!
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling